Difference between revisions of "Salvia miltiorrhiza"
Jump to navigation
Jump to search
ICG Expert3 (talk | contribs) |
|||
| Line 66: | Line 66: | ||
[[Category:Plants]] [[Category:mRNA]] [[Category:SYBR]] | [[Category:Plants]] [[Category:mRNA]] [[Category:SYBR]] | ||
[[Category:ACT]] [[Category:Ubiquitin]] | [[Category:ACT]] [[Category:Ubiquitin]] | ||
| + | [[Category:Different Tissues]] | ||
Revision as of 14:52, 21 June 2017
Contents
Description
- Salvia miltiorrhiza, Danshen in Chinese, is a highly valued traditional Chinese medicine for the treatment of atherosclerosis-related disorders, such as cardiovascular and cerebrovascular diseases in China.
- Salvia miltiorrhiza root has long been used in Asian countries for clinical treatment of various microcirculatory disturbance-related diseases.
- For several decades, Salvia miltiorrhiza root has been widely used in clinics in China, Korea, Japan and other Asian countries for the treatment of various microcirculatory disturbance-related diseases, such as cardiovascular disease, cerebrovascular disease, liver dysfunction, renal deficiency and diabetic vascular complication[1] [2] .
Different Tissues
Reference Genes
| Gene Symbol | Gene Name | Application Scope | Accession Number | Primers (5'-3') [Forward/Reverse] |
Size [bp] | Tm [℃] | Detection |
|---|---|---|---|---|---|---|---|
| Actin[1] | Cytoskeletal structural protein |
|
NA |
|
278 | 58 | SYBR |
| Ubiquitin[1] | Ubiquitin protein |
|
NA |
|
146 | 58 | SYBR |
Moleculer Type
- mRNA
Evaluation Methods
Contact
- Name: Luqi Huang
- Email: huangluqi@263.net
- Institution: Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, 100700 Beijing, China
Citation Statistics
Cited by 63 (Based on Google Scholar [2017-06-16])
References
- ↑ 1.0 1.1 1.2 Yang Y, Hou S, Cui G, et al. Characterization of reference genes for quantitative real-time PCR analysis in various tissues of Salvia miltiorrhiza[J]. Molecular biology reports, 2010, 37(1): 507-513.
- ↑ Han J Y, Fan J Y, Horie Y, et al. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion[J]. Pharmacology & therapeutics, 2008, 117(2): 280-295.
